Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Synlogic, Inc. (SYBX : NSDQ)
 
 • Company Description   
Synlogic, Inc. engaged in the development of a novel class of living Synthetic Biotic(TM) medicines based on its proprietary drug discovery and development platform. The company's pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases such as Urea Cycle Disorder and Phenylketonuria. In addition, the company is leveraging the broad potential of its platform to create Synthetic Biotic medicines for the treatment of other diseases, such as liver disease, inflammatory and immune disorders and cancer. It is collaborating with AbbVie to develop Synthetic Biotic-based treatments for inflammatory bowel disease. Synlogic Inc., formerly known as Mirna Therapeutics Inc., is based in Cambridge, Massachusetts.

Number of Employees: 84

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.21 Daily Weekly Monthly
20 Day Moving Average: 150,635 shares
Shares Outstanding: 70.25 (millions)
Market Capitalization: $85.00 (millions)
Beta: 1.56
52 Week High: $4.54
52 Week Low: $1.02
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -34.60% -26.33%
12 Week -34.24% -27.70%
Year To Date -50.00% -38.91%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
301 Binney St. Suite 402
-
Cambridge,MA 02142
USA
ph: 617-401-9975
fax: 512-681-5201
dan.rosan@synlogictx.com http://www.synlogictx.com
 
 • General Corporate Information   
Officers
Aoife Brennan - President and Chief Executive Officer
Peter Barrett - Chairman
Gregg Beloff - Interim Chief Financial Officer
Michael Burgess - Director
Michael Heffernan - Director

Peer Information
Synlogic, Inc. (CORR.)
Synlogic, Inc. (RSPI)
Synlogic, Inc. (CGXP)
Synlogic, Inc. (BGEN)
Synlogic, Inc. (GTBP)
Synlogic, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 87166L100
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 70.25
Most Recent Split Date: 8.00 (0.14:1)
Beta: 1.56
Market Capitalization: $85.00 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.29 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.90 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.64
Price/Cash Flow: -
Price / Sales: 42.54
EPS Growth
vs. Year Ago Period: 38.89%
vs. Previous Quarter: -4.76%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -58.78%
ROE
03/31/22 - -43.07
12/31/21 - -44.37
09/30/21 - -46.75
ROA
03/31/22 - -35.97
12/31/21 - -36.82
09/30/21 - -38.31
Current Ratio
03/31/22 - 12.87
12/31/21 - 13.23
09/30/21 - 14.79
Quick Ratio
03/31/22 - 12.87
12/31/21 - 13.23
09/30/21 - 14.79
Operating Margin
03/31/22 - -3,067.42
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -3,067.42
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -3,067.42
12/31/21 - -3,452.74
09/30/21 - -5,168.67
Book Value
03/31/22 - 1.88
12/31/21 - 2.11
09/30/21 - 2.32
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.01
12/31/21 - 0.01
09/30/21 - 0.01
 

Powered by Zacks Investment Research ©